Purchase Order SPE2DP24V1915
- Not listed
- This contract was awarded to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business, to provide naloxone hydrochloride, a medication used to reverse opioid overdose. The $1,005.03 firm fixed-price purchase order was issued by the Defense Logistics Agency's Medical Supply Chain division. The Maclean Group is an ISO 9001:2015 certified medical and pharmaceutical wholesale distributor that has been awarded numerous prime federal...
- This $3,015.09 firm fixed-price purchase order was awarded to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business based in Jacksonville, Florida. The contract was awarded by the Defense Logistics Agency's Medical Supply Chain Division for the delivery of naloxone hydrochloride, a medication used to reverse opioid overdose. The contract has an ultimate completion date of December 9, 2024. The Maclean Group LLC is an ISO 9001:2015...
- The U.S. Defense Logistics Agency (DLA) awarded a $6,030.18 firm-fixed-price purchase order contract to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business, for the supply of 8510598495 - NALOXONE HYDROCHLOR. The contract has an ultimate completion date of May 13, 2024. The Maclean Group is an ISO 9001:2015 certified medical and pharmaceutical wholesale distributor that holds several significant federal contract vehicles,...
- This is a firm fixed price purchase order contract awarded by the Medical Supply Chain, a component of the Department of Defense, to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business. The contract, valued at $2,010.06, is for the delivery of naloxone hydrochloride, a medication used to reverse opioid overdose. The contract has a performance period ending on May 10, 2024. The Maclean Group is an ISO 9001:2015 certified...
- This federal contract was awarded by the Department of Defense's Medical Supply Chain agency to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business. The $3,015.09 firm fixed-price purchase order is for the supply of naloxone hydrochloride, a critical medication used to reverse opioid overdoses. The contract has an ultimate completion date of August 16, 2024 and was awarded on August 1, 2024 with no set-aside designation. The...
- The U.S. Defense Logistics Agency (DLA) awarded a $2,010.06 firm-fixed-price purchase order contract to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business, for the supply of 8510594132 - Naloxone Hydrochloride. The contract does not have a set-aside designation and has an ultimate completion date of May 10, 2024. The Maclean Group is a medical and pharmaceutical wholesale distributor that holds several significant federal...
- This firm-fixed-price purchase order was awarded to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business, to provide naloxone hydrochloride to the Defense Logistics Agency's Medical Supply Chain. The $1,005.03 contract has an ultimate completion date of August 1, 2024. The Maclean Group is an ISO 9001:2015 certified medical and pharmaceutical wholesale distributor that has been awarded multiple federal contracts, including a...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price purchase order contract worth $2,010.06 to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business, for the supply of naloxone hydrochloride. The contract has a performance period ending on May 13, 2024. The Maclean Group is an ISO 9001:2015 certified medical and pharmaceutical wholesale distributor that provides a range of products and services to federal...
- This federal contract award, valued at $1,005.03, was issued by the Defense Logistics Agency (DLA) to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business. The contract is for the delivery of naloxone hydrochloride, a medication used to reverse opioid overdose, and has an ultimate completion date of October 3, 2024. The Maclean Group is an ISO 9001:2015 certified medical and pharmaceutical wholesale distributor that has been...
- The U.S. government's Defense agency, specifically the Medical Supply Chain, has awarded a $4,020.12 firm fixed-price purchase order contract to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business. The contract is for the delivery of Naloxone Hydrochloride, a medication used to reverse opioid overdose, with a completion date of June 18, 2024. The Maclean Group is an ISO 9001:2015 certified medical and pharmaceutical wholesale...
This contract was awarded by the Defense Logistics Agency (DLA) to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business. The $18,090.54 firm fixed-price purchase order is for the delivery of 8510751637 - Naloxone Hydrochloride, a critical medication used to reverse opioid overdoses. The contract has a 100% small business set-aside and is scheduled for completion by July 29, 2024. The Maclean Group is an ISO 9001:2015 certified medical and pharmaceutical wholesale distributor that has been awarded numerous prime federal contracts to provide a variety of goods and services, including medical equipment, water treatment systems, facility maintenance, and professional support services for agencies such as the Department of Veterans Affairs, Department of Defense, and Department of the Interior.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.1k | 7/12/24 |